SOL-1 is now expected to be enrolled and fully randomized by year-end 2024Topline clinical data from SOL-1 are now expected in Q4 2025BEDFORD, ...

Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on Neumora Therapeutics, Inc. (NMRA – Research ...

The new FanDuel Sportsbook promo offers users a chance to earn $300 in bonus bets if their first $5 wager wins. Plus, receive ...

FanDuel has a new offer ahead of the NBA season. Claim $300 in bonus bets and three months of NBA League Pass if your first ...

This post contains details from Episode 3 of Agatha All Along ... inviting them to the First Trial. The card inside contains a riddle: “My age has value. I’m no fun alone.

GSK’s blockbuster hopes for depemokimab remain on track after the investigational long-acting asthma treatment has also been shown to reduce nasal polyps in a pair of phase 3 trials. The ANCHOR ...

The phase 3 trial assessed dapirolizumab pegol, an anti-CD40L drug candidate that Biogen and UCB have been jointly developing since 2003. A phase 2b trial of the molecule missed its primary ...

Although these drugs are generating excitement, only a few clinical trials of protein degraders are underway, including a phase 3 trial by Arvinas (in partnership with Pfizer) of vepdegestrant ...

An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Oral Simufilam in On-going Phase 3 Trials. The DSMB Recommended Both Phase 3 ...

The Data and Safety Monitoring Board (DSMB), made up of independent clinical research experts, reviewed patient safety data from Cassava’s Phase 3 trials but did not assess the drug's efficacy.

27, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it will unveil study design details of SONATA-HCM, the company’s Phase 3 clinical trial of ...